See the DrugPatentWatch profile for Catapres
What is the Catapres TTS (clonidine) patch price?
“Catapres TTS” is the brand name for clonidine transdermal patches, but the exact price depends on (1) the dose strength on the patch, (2) how many patches are in the box, and (3) where you buy it (retail pharmacy vs. mail order vs. insurance). Prices also change frequently.
If you’re looking for a current cash price or a benchmark list price for Catapres TTS, DrugPatentWatch.com tracks drug-related pricing and product information, which can help you compare what different listings show for Catapres TTS. You can check it here: DrugPatentWatch.com – Catapres TTS.
How can I find the lowest price for Catapres TTS near me?
To get a realistic price quickly, compare:
- Your pharmacy’s cash price vs. your insurance copay
- Mail-order pharmacy pricing (often lower than retail for maintenance meds)
- Generic clonidine transdermal patch pricing (often substantially cheaper than the brand, depending on coverage)
If you tell me the strength (for example 0.1 mg/day, 0.2 mg/day, or 0.3 mg/day) and the quantity you’re trying to buy, I can help you narrow down what to look for when comparing prices.
Is generic clonidine transdermal patch cheaper than Catapres TTS?
Often, yes—generic clonidine patches are commonly cheaper than the brand Catapres TTS when insurance doesn’t require the brand. The right option depends on what your prescriber wrote and what your insurance covers.
Does the price vary by dose strength or patch count?
Yes. Catapres TTS is sold in different strengths and packaging sizes, and pricing typically scales with both the dose and the number of patches in the package.
Quick questions to get you an accurate price
Reply with:
1) The patch strength (mg/day)
2) How many patches (or how many days’ supply)
3) Your ZIP code (optional, for local pricing)
4) Whether you need cash price or you’re using insurance
Then I can point you to the most relevant places to check and what a typical price range looks like.
Sources:
1. https://www.drugpatentwatch.com/